(UK) measured over the triennium 1954-56, whilst mortality from MND was much the same in the two countries.
Recent State and regional multiple sclerosis prevalence surveys in Australia" 2 have also shown a strong association between disease frequency and latitude, with multiple sclerosis frequency increasing about fourfold in a southerly direction across the continent. Furthermore, multiple sclerosis prevalence in English-born migrants was found to be considerably lower than that found recently in England'3 '4 in all except the southernmost areas of Australia. The principal aims of this study were firstly, to see if the findings of the recent multiple sclerosis prevalence surveys in Australia were supported by mortality statistics for the decade 1971-80 prior to the surveys, and secondly, to make a comparison between these mortality data and those obtained by Acheson." Finally, the reliability of such mortality data in estimating the frequency of multiple sclerosis in Australia was assessed by a comparison with data on deaths among known multiple sclerosis patients in the State of New South Wales (NSW). 
Results
Temporal trends in multiple sclerosis mortality: (a) Australia-the decades 195S0-59 and 1971-80 Table 1 shows that the age-standardised mortality of multiple sclerosis in Australia had declined in each State in the more recent decade with the exception of WA where multiple sclerosis mortality had remained essentially stable. The falls in mortality were greater than could be explained by chance in Australia as a whole (28%, p < 0 0001) and in the States of QLD (53%, p < 0-0001), NSW (31%, p < 0-001) and Victoria (23%, p < 0004) but not in SA (13%, p > 0-42) or Tas (34%, p > 0 07). there were no recorded deaths from multiple sclerosis in either territory in the earlier decade.
The contribution ofmortality statistics to the study ofmultiple sclerosis in Australia (b) United Kingdom-the triennia 1954-56 and 1974-76 Table 2 shows that the age-standardised mortality of multiple sclerosis in the UK had declined by 19% (p < 0-0001) in the more recent triennium. This trend was seen in each of its constituent countries, the falls all being greater than could be explained by chance (Scotland 42%, p < 0-0001; England and Wales 14%, p < 0-0001; Northern Ireland 25%, p < 0-03). Comparison ofmultiple sclerosis mortality in the United Kingdom and Australia In both time periods of comparison, the age-standardised mortality from multiple sclerosis was substantially higher in the UK (table 2) than in Australia (table 1) (first period: RR 2-39, 95% CI 2-20-2-60, p < 0-0001; second period: RR 2-70, 95% CI 2 50-2-92, p < 0 0001). Age-specific mortality in the more recent time period of comparison showed a monophasic pattern in both countries ( fig. 1) , peaking around the sixth to seventh decades of life with a decline thereafter; the peak for females and all persons was slightly later in Australia than in the UK. An excess of females was also apparent in both countries, the female:male ratios being 1 9:1 and 1 6:1 in Australia and the UK respectively, the figure for Australia being similar to that found in the five 1981 regional prevalence surveys combined (2.4:1).
Of the 713 deaths from multiple sclerosis in Australia from 1971-80, 561 (79%) subjects were born in Australia and 72 (10%) in the UK. Age-standardised (1950 US population) mortality was 0 57 in the Australian-born population and 0-44 in the UK-born population, a difference just exceeding that which could be explained by chance (RR 1P30, 95% CI 1 01-1 67, p < 005). However, the difference in age- The contribution ofmortality statistics to the study ofmultiple sclerosis in Australia known to the NSW prevalence survey (non-UCD group); of these, 64 (67%) had multiple sclerosis listed as a contributing cause of death (CCD) whilst in the remaining 31 (33%) multiple sclerosis did not appear on the death certificate. As a measure of prevalence of multiple sclerosis at death in that time interval, therefore, the official mortality statistics in NSW provided an underestimate of 29% (ABS listed deaths
---------------------------------------------------
[230]/total multiple sclerosis deaths [322] ) or 30% if the three rejected cases are excluded. Even if all causes of death had been coded on death certificates, 10% of deaths (31/322) in multiple sclerosis patients would still have been missed.
Discussion
Mortality statistics in most countries, including Australia, include only those deaths in which multiple sclerosis has been coded as the UCD in their cause-ofdeath statistics. Studies based solely on this source of information will, therefore, underestimate the frequency of multiple sclerosis at death. This is exemplified by the study of multiple sclerosis death certification in NSW. The prevalence of multiple sclerosis at death was underestimated by at least onequarter in NSW. Furthermore, one-tenth of deaths in multiple sclerosis patients in NSW had no mention of multiple sclerosis on their death certificates and these would have been missed even with multiple-causecoding. Other studies have shown similar trends: the proportion of multiple sclerosis deaths in which multiple sclerosis was not coded as the UCD varied from 18% 18 to 55%,'9 and with no mention ofmultiple sclerosis at all on the death certificate from 10%' to 26%. '9 In Australia, however, it is unlikely that in recent times there would have been any major interstate differences in the extent to which such mortality statistics underestimate the frequency of multiple sclerosis because medical services are similar in all States and ofa uniformly high standard. Certainly, the striking gradient of disease frequency with latitude shown by mortality statistics for the decade 1971-80 (table 3; fig 2) seems unlikely to be artifactual for a number of reasons. Firstly, it confirms Acheson's'°f inding of two decades previously; moreover, in the present study, QLD also conformed to the pattern. Secondly, it is unlikely that the gradient could be explained by any major interstate differences in the case-fatality ratio; indeed, the 1981 morbidity studies suggested that the disease may actually run a more malignant course in the hotter northerly regions of Australian' rather than the reverse. Thirdly, and perhaps most importantly, it is clearly consistent with and very similar to the gradient shown by the 1981 prevalence surveys."' 2 A similar consistency between prevalence and mortality data in relation to multiple sclerosis frequency variations with latitude has recently been shown in neighbouring New Zealand2"22 and in the USA. 5 The minor inconsistency in the multiple sclerosis frequency gradient with latitude shown by the 1981 prevalence surveys in Australia was most probably related to the differing sizes of the populations surveyed because case ascertainment is generally more complete with smaller population surveys. 2 12 23 Indeed, the latter observation constitutes a possible source of criticism of the overall strength of the association between multiple sclerosis prevalence and latitude within Australia; this is particularly true of its extremes because the QLD population surveyed in 1981 (2,295,122) was considerably larger than that of the Hobart statistical division (168,363). The fact that the multiple sclerosis mortality figures confirmed this frequency gradient is, therefore, of considerable importance because its data collection was entirely independent of the prevalence surveys. Furthermore, the mortality gradient with latitude showed no anomalies and it extended the association to include areas where we were unable to get prevalence data. Although the multiple sclerosis frequency gradient with latitude is thought to be partly due to genetic factors in some countries,9122' there is no convincing evidence that this is the case in Australia,'2 thus arguing strongly for the existence of an important environmental factor in the aetiology of multiple sclerosis.
Mortality Acheson' s'°hypothesis and suggests that while the majority of the fall in the multiple sclerosis mortality rate in Australia in the more recent decade almost certainly was due to a genuine decline in mortality, part at least was due to resolution of this nosological confusion.
Over much the same time period, mortality from multiple sclerosis in the countries of the UK had also fallen substantially (table 2) .89 However, the considerable difference between multiple sclerosis in the UK and Australia noted by Acheson'" was still apparent in the present study. More importantly, Acheson' s26 further observation that mortality from multiple sclerosis in UK migrants dying in Australia (1957-61) was slightly lower after age-standardisation than that of the Australian-born population and very much lower than that of the native UK population, was also confirmed in the present study. One possible explanation for this finding is that the migrant population from the UK was preselected to exclude those people with established multiple sclerosis. However, as Acheson26 himself commented, it seems questionable that differences of this magnitude could be entirely explained by preselection. In this regard, it is also interesting to note that 26% ofall UK-born patients in the 1981 Australian multiple sclerosis prevalence surveys experienced disease onset prior to migration (Hammond et al, unpublished observations). Hence, when taken in conjunction with the findings among English-born migrants in the 1981 prevalence surveys,"1 12 a further, and perhaps more likely, explanation for this discrepancy is that migration from the UK to all but the southermost parts of Australia may lower the risk of developing multiple sclerosis either through a reduction in disease incidence or the operation of environmental factors curbing disease expression.
Kurtzke has stressed the importance of seeking "support from other approaches for any conclusions or inferences attained in any epidemiologic work".27 It seems clear from the present study and from recent studies in the USA' and New Zealand' that, in multiple sclerosis at least, mortality statistics may provide a valuable source ofsupport for data obtained from prevalence surveys.
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